Vimizim (elosulfase alfa)

pCPA File Number: 20945

Negotiation Status:

Concluded with an LOI

Indication(s):

Mucopolysaccharidosis IVA (Morquio A syndrome)

Sponsor/Manufacturer:

BioMarin Pharmaceutical Inc.

CDA-AMC Project Number:

SR0456-000

pCPA Engagement Letter Issued:

2016-10-28

Negotiation Process Concluded:

2018-11-29